What is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)?
- A rare form of lymphoma (a cancer of the immune system developing from lymphocytes), and a malignancy of the blood.
- A distinct type of Anaplastic Large Cell Lymphoma (ALCL) involving the capsule or effusion surrounding a breast implant.
- It occurs occurs at a mean of eight years following implantation.
How common is BIA-ALCL?
- Less than ten patients are diagnosed per year with this disease.
- 118 distinct cases have been reported, and MD Anderson Cancer Center recognizes 160 cases worldwide of pathologically confirmed BIA-ALCL to date from fifteen countries.
- Breast Implants: Lymphoma / Blood Cancer Cases Overview
- Breast Implants and Lymphoma: Summary of Information
- Breast Implants and Lymphoma: The Disease
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Resources
- Breast Implants and Lymphoma: Frequently Asked Questions